| HIV Infection |
1 |
1 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.99 |
| Patient Safety |
0 |
0.76 |
| Europe |
0 |
0.37 |
| Generics |
0 |
0.37 |
| Salary and Compensation |
0 |
0.37 |
| Transgender |
0 |
0.37 |
| Preexposure HIV Prophylaxis |
0 |
0.32 |
| Social Determinants of Health |
0 |
0.26 |
| Adherence |
0 |
0.19 |
| Adverse Effects |
0 |
0.19 |
| AIDS |
0 |
0.19 |
| Birth |
0 |
0.19 |
| California |
0 |
0.19 |
| Epidemic |
0 |
0.19 |
| France |
0 |
0.19 |
| HIV Prevention |
0 |
0.19 |
| Nodule |
0 |
0.19 |
| Prophylaxis |
0 |
0.19 |
| Stigma |
0 |
0.19 |
| UK Site Content |
0 |
0.19 |
| Revenue and Practice Management |
0 |
0.12 |